PER percheron therapeutics limited

Ann: Topline Six-Month Results From Phase IIb Study of Avicursen, page-118

  1. 1,111 Posts.
    lightbulb Created with Sketch. 260
    Thanks Dave........it sure has been nice having you on this thread. Hope your sons are having a good experience with their share investments. My only other biotechs are ATH and IMU. I remain optimistic about IMU's chances of a cancer vaccine and cure......... imagine how many people will be saved. Very best wishes Dave. Cheers........Learnersmile.png
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.2¢ 1.3¢ 1.0¢ $277.9K 24.26M

Buyers (Bids)

No. Vol. Price($)
11 2273797 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 5066000 5
View Market Depth
Last trade - 16.14pm 26/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.